I make a donation

AFLOAT

Efficiency of flecainide to prevent AF occurence after PFO closure

En cours

Bourses ACTION & PHRA 2022

Colloquium "La cardiologie préventive : nouveautés" (mardi 1er avril 2025)
Réservez vos places !

La Fondation de l'AP-HP attribue le Grand Prix Scientifique 2024 au Pr Gilles Montalescot

P&R Agenda
Au programme prochainement...

objectif

To assess if flecainide is more efficient than standard of care (control group) to prevent AF occurrence during the 3 months after PFO closure.

date de réalisation

2021

nombre de patients

186

nombre de centres participants

16 french sites

type de financement

Fonds de Dotation Action & Abbott

Référence

NCT05213104

A study conducted by Fonds de Dotation ACTION.
Find out details and results on the dedicated page

AFLOAT conducted by Fonds de Dotation ACTION

Autres études

ACORES-2

En cours

Evaluate the effect of RAS blockers discontinuation versus continuation on clinical course of patients infected with COVID-19.

ANCHOR

En cours

Demonstrate the superiority of an association of VA-ECMO and IABP with an optimal medical treatment compared with an optimal medical treatment only in cardiogenic shock AMI patients

EDUC-DAI

En cours

Impact of therapeutic education on the quality of life and the anxiety of patients with a defibrillator.